Výsledky vyhledávání - "Cheryl V. Wong"

Abstract CT217: 3-year update of neoadjuvant atezolizumab + chemotherapy in patients with resectable non-small cell lung cancer

Autor: Brian S. Henick, Justin F. Gainor, Mark M. Awad, Codruta Chiuzan, Stephanie Izard, Yohanna Georgis, Peter D. Koch, Robert F. Garofano, Cheryl V. Wong, Anjali Saqi, Jessica M. Grindheim, Katja Schulze, Naiyer A. Rizvi, Benjamin Izar, Alison M. Taylor, Catherine A. Shu

Publikováno v: Cancer Research. 83:CT217-CT217

Introduction: Neoadjuvant chemoimmunotherapy is promising in improving outcomes for patients with resectable lung cancer in the phase III setting, though data are immature at this time for overall survival (OS). Here, we present outcomes after 3 year

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af20edcbb6e03c99bca0885c2f68a7d0
https://doi.org/10.1158/1538-7445.am2023-ct217

Zobrazit plný text záznamu

Akademický článek

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.

Autor: Doris Kim, YounJeong Choi, James Ireland, Oded Foreman, Rachel N Tam, Rajesh Patel, Erica B Schleifman, Maipelo Motlhabi, Dorothy French, Cheryl V Wong, Eric Peters, Luciana Molinero, Rajiv Raja, Lukas C Amler, Garret M Hampton, Mark R Lackner, Omar Kabbarah

Publikováno v: PLoS ONE, Vol 11, Iss 11, p e0165856 (2016)

In the age of personalized medicine stratifying tumors into molecularly defined subtypes associated with distinctive clinical behaviors and predictable responses to therapies holds tremendous value. Towards this end, we developed a custom microfluidi

Externí odkaz: https://doaj.org/article/6b49b7df79184ff786c816a2ccf4acec

Zobrazit plný text záznamu

Detection of minimal residual disease (MRD) in colorectal cancer (CRC) patients UICC stage II/III by ultra-deep sequencing of cfDNA from post-surgery plasma

Autor: Sylvie McNamara, Rajesh D. Patel, Hans-Peter Adams, Xueping Qu, Bernd Hinzmann, Cheryl V Wong, Gabrielle Heilek, Renè Mantke, Michael Heise, Thomas Steinmüller, Matthias Pross, Frank Marusch, Carlos Bais, John F. Palma

Publikováno v: Journal of Clinical Oncology. 40:26-26

26 Background: Detection of primary tumor mutations in cell-free DNA (cfDNA) of post-surgery plasma of patients with R0-resected not-metastasized solid tumors is a strong indicator of recurrence of disease. We explored whether ultra-deep sequencing o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::008ad3e0d26801c9aaf77c8b0920a80f
https://doi.org/10.1200/jco.2022.40.4_suppl.026

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání